Connection

Olga Brawman-Mintzer to Anti-Anxiety Agents

This is a "connection" page, showing publications Olga Brawman-Mintzer has written about Anti-Anxiety Agents.
Connection Strength

1.074
  1. Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study. J Clin Psychiatry. 2005 Oct; 66(10):1321-5.
    View in: PubMed
    Score: 0.256
  2. Generalized anxiety disorder: acute and chronic treatment. CNS Spectr. 2004 Oct; 9(10):716-23.
    View in: PubMed
    Score: 0.239
  3. New trends in the treatment of anxiety disorders. CNS Spectr. 2004 Aug; 9(8 Suppl 7):19-27.
    View in: PubMed
    Score: 0.236
  4. Pharmacologic treatment of generalized anxiety disorder. Psychiatr Clin North Am. 2001 Mar; 24(1):119-37.
    View in: PubMed
    Score: 0.186
  5. Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. J Clin Psychiatry. 2010 May; 71(5):627-31.
    View in: PubMed
    Score: 0.086
  6. Anxious depression. J Clin Psychiatry. 1998; 59 Suppl 18:10-7.
    View in: PubMed
    Score: 0.037
  7. Generalized anxiety disorder: issues in epidemiology. J Clin Psychiatry. 1996; 57 Suppl 7:3-8.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.